Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0991 in Indian adults with persistent fever and neutropenia
NCT00379964Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2005
- Primary completion
- May 2006
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
A Phase 3 trial of caspofungin in fungal infection, sponsored by Merck & Co.. Started Jun 2005; status: completed.
02
Drugs
caspofungin
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT00379964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00379964.